Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Lezhu Pharmaceutical Co., Ltd., formerly known as Suzhou Tianlong Pharmaceutical, is a specialized pharmaceutical company headquartered in the Suzhou Industrial Park, China, dedicated to the field of ophthalmology. Since its formal establishment in 1999, the company has developed a comprehensive portfolio of eye care products, ranging from local anesthetics and anti-infectives to treatments for dry eye and allergic conjunctivitis. Notable products include Proparacaine hydrochloride eye drops for surgical anesthesia and Pearl Eye Drops, a traditional Chinese medicine-based solution for vision fatigue. The company maintains advanced manufacturing facilities that comply with GMP standards and continues to innovate through the development of new ophthalmic formulations. With a focus on quality and innovation, Suzhou Lezhu Pharmaceutical aims to be a leader in the Chinese ophthalmic drug market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzhou Lezhu Pharmaceutical.